Gabriela Calzada

Dr. Calzada has over 20 years of continuous experience in research. She received her DMV and M.Sc. degrees in Mexico before moving to the U.S. to complete a Ph.D. in Pathobiology at the University of Illinois at Urbana-Champaign. Here, she gained extensive experience in animal trial design and monitoring, as well as in immunology against major swine diseases such as PRRSv. Dr. Calzada is the inventor of a patent and has been awarded federal research funding. She began her career in vaccine development at Biotell, a CMO of animal health products in Mexico, where she was responsible for viral vaccine production for small animals. At Aptimmune, Dr. Calzada leads research and vaccine development of novel mucosal vaccines. She works closely with international consultants, Contract Research Organizations, and Contract Manufacturing Organizations to ensure all aspects of vaccine manufacturing occur in compliance with protocols and regulations.